Chee Chin Aik
About Chee Chin Aik
Chee Chin Aik (age 45) serves as an independent director of Agape ATP Corporation (ATPC) since 2023; he brings ~20 years of finance experience and currently leads South East Asia cash and non‑cash equity sales within Global Markets at HSBC Singapore . His education includes a BA (Franklin & Marshall College) and an MBA in Finance (University of Chicago Booth School of Business) . The Board has affirmatively determined he meets Nasdaq independence requirements . He chairs ATPC’s Nominating & Corporate Governance Committee and sits on the Audit and Compensation Committees .
Past Roles
| Organization | Role | Tenure | Location/Notes |
|---|---|---|---|
| HSBC Singapore | Head of South East Asia, Cash and Non‑Cash Equity Sales, Global Markets | Current | Singapore |
| JPMorgan Chase & Co. | Executive Director; Head of Malaysia Equity Distribution; Board Member | Oct 2020 – May 2022 | Malaysia/Singapore; Board member noted |
| Credit Suisse (Malaysia & Singapore) | Director, Institutional Equity Sales | Jan 2019 – Sep 2020 | Malaysia & Singapore |
| Credit Suisse (Singapore) | Vice President, Institutional Equity Sales | Jan 2015 – Dec 2018 | Singapore |
| Credit Suisse (Singapore) | Associate, Institutional Equity Sales | Apr 2013 – Dec 2014 | Singapore |
| Aminvestment Bank Berhad | Analyst & Trader, Equity Derivatives & Proprietary Trading | Jan 2009 – Aug 2011 | Malaysia |
| Credit Lyonnais Securities Asia Pacific Markets (CLSA) | Equity Research Analyst | Oct 2007 – Sep 2008 | Malaysia |
| Goldman Sachs (FICC) | Associate, Fixed Income Currencies & Commodities | Oct 2006 – Jul 2007 | USA |
| Lehman Brothers | Analyst, Fixed Income Corporate Advisory Division | Jul 2004 – Oct 2006 | USA |
| National Association of Securities Dealers (FINRA) | Associate, Financial Regulatory & Cycle Examination Group | Jun 2002 – Jul 2004 | USA |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| HSBC Singapore | Head, SEA Cash & Non‑Cash Equity Sales, Global Markets | Current | N/A |
| JPMorgan Chase & Co. | Executive Director; Head of Malaysia Equity Distribution; Board Member | Oct 2020 – May 2022 | Board member (interlock potential) |
Board Governance
- Independence: Board determined Chee Chin Aik is independent under Nasdaq Listing Rules .
- Committees and Chairs: Member—Audit and Compensation; Chair—Nominating & Corporate Governance .
- Risk oversight: Board/independent directors engage directly on material risks and conflicts; Audit Committee reviews and pre‑approves related‑party transactions .
| Committee | Members | Chair | Independence |
|---|---|---|---|
| Audit | Ramesh Ruben Louis, PhD; Vong John Hing, PhD; Chee Chin Aik | Ramesh Ruben Louis, PhD | All members independent (SEC/Nasdaq) |
| Compensation (Remuneration) | Ramesh Ruben Louis, PhD; Vong John Hing, PhD; Chee Chin Aik | Vong John Hing, PhD | All members independent (Nasdaq) |
| Nominating & Corporate Governance | Ramesh Ruben Louis, PhD; Vong John Hing, PhD; Chee Chin Aik | Chee Chin Aik | All members independent (Nasdaq) |
| Body | Meetings in 2023 | Attendance Note |
|---|---|---|
| Board | 3 | No director attended <75% of aggregate meetings |
| Audit Committee | 0 | No director attended <75% of aggregate meetings |
| Compensation (Remuneration) Committee | 1 | No director attended <75% of aggregate meetings |
| Nominating & Corporate Governance Committee | 1 | No director attended <75% of aggregate meetings |
Other Directorships & Interlocks
| Company | Role | Tenure | Interlock/Notes |
|---|---|---|---|
| JPMorgan Chase & Co. | Board Member; Executive Director; Head of Malaysia Equity Distribution | Oct 2020 – May 2022 | Potential information flow/interlock due to prior board seat |
Expertise & Qualifications
- Capital markets leadership across Asia (institutional equity sales; derivatives trading; research) .
- Regulatory and compliance exposure from FINRA tenure (U.S.) .
- Academic credentials: BA (Franklin & Marshall), MBA Finance (Chicago Booth) .
Governance Assessment
- Strengths: Independent status and chairmanship of Nominating & Governance position him to influence director selection and governance policies; breadth of sell‑side and regulatory background adds capital markets and compliance expertise to ATPC’s board .
- Attendance/Engagement: Board and committees met during 2023 with no director below 75% attendance, supporting engagement expectations .
- Conflicts Monitoring: Current HSBC leadership and prior JPMorgan board role may create potential counterparty/interlock considerations if ATPC engages these institutions; mitigation exists via Audit Committee chartered oversight of related‑party transactions and independence across committees .
- Investor Confidence Signal: The company’s 2025 special meeting proposals contemplate a significant share issuance resulting in ~92% post‑transaction ownership by Regulation S investors, deemed a change of control under Nasdaq Rule 5635(b); this concentration raises governance vigilance requirements for independent directors, including Chee, on minority shareholder protections .